BLS Pharmaceuticals Limited (BLS, formerly Bioxyne Limited) is an Australian pharmaceutical company focused on the development manufacture and commercialization of medicines final patient dosage forms and active pharmaceutical ingredients.
Find out what a historical investment in BLS Pharmaceuticals Limited would be worth today using our BLS stock calculator.
Buying BLS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in BLS Pharmaceuticals Limited in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in BLS
What is the ticker symbol of BLS Pharmaceuticals Limited?
The ticker symbol for BLS Pharmaceuticals Limited is BLS.
How much is one share of BLS?
One share of BLS is valued at $0.83 as of 20 November 2026.
What is the market capitalisation of BLS Pharmaceuticals Limited BLS?
As of 20 November 2026 BLS Pharmaceuticals Limited has a market cap of $196.19M.
What is the P/E ratio of BLS?
The Price to Earnings ratio of BLS is 12.39.
What is the Earnings Per Share of BLS?
The Earnings Per Share of BLS is $0.07.
What is the 52-week high for BLS Pharmaceuticals Limited stock?
The BLS Pharmaceuticals Limited 52-week high stock price is $1.30.
What is the 52-week low for BLS Pharmaceuticals Limited stock?
The BLS Pharmaceuticals Limited 52-week low stock price is $0.35.
Can I buy BLS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BLS shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.